Cardiovascular Diabetology
JULY 15, 2024
Myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) is a debilitating chronic condition that is characterized by unresolved fatigue, post-exertion symptom exacerbation (PESE), cognitive dysfunction, or.
Med Page Today
JULY 15, 2024
(MedPage Today) -- COVID-19 may accelerate progression of presymptomatic type 1 diabetes in youth, a German study suggested. Incidence of clinical type 1 diabetes nearly doubled after the pandemic started among 591 youth ages 1 to 16 known to.
DAIC
JULY 15, 2024
mtaschetta-millane Mon, 07/15/2024 - 11:18 July 15, 2024 — HeartBeam, Inc. , a medical technology company focused on transforming cardiac care through the power of personalized insights, today announced new study data demonstrating that HeartBeam AI combined with vectorcardiography (VCG) outperformed an expert panel of heart rhythm cardiologists in detecting atrial flutter.
American Heart News - Heart News
JULY 15, 2024
Research Highlights: A comparison of two tools for calculating cardiovascular disease risk found that if only the current 10-year risk thresholds are applied, fewer adults may be recommended for blood pressure-lowering medication. The tools, The.
Science Daily - Heart Disease
JULY 15, 2024
According to a new study, both 30-year risk for cardiovascular disease in addition to 10-year risk may be considered in making decisions about when to initiate high blood pressure medication.
Journal of Clinical Investigation - Cardiology
JULY 15, 2024
A growing body of research has identified circadian-rhythm disruption as a risk factor for metabolic health. However, the underlying biological basis remains complex, and complete molecular mechanisms are unknown. There is emerging evidence from animal and human research to suggest that the expression of core circadian genes, such as circadian locomotor output cycles kaput gene (CLOCK), brain and muscle ARNT-Like 1 gene (BMAL1), period (PER), and cyptochrome (CRY), and the consequent expression
DAIC
JULY 15, 2024
Getty Images mtaschetta-millane Mon, 07/15/2024 - 11:06 July 15, 2024 — Edwards Lifesciences announced it has exercised its option to acquire Innovalve Bio Medical Ltd. , an early-stage transcatheter mitral valve replacement (TMVR) company, following its initial investment in 2017. Since that time, Innovalve has demonstrated progress in its program with promising early clinical experience.
Cardiovascular Update brings together the best content for cardiovascular medicine professionals from the widest variety of industry thought leaders.
DAIC
JULY 15, 2024
A strategic deal to deliver virtual value-based cardiology care to health systems has been announced by the Dallas, TX-based executive team at Guidehealth, a provider of AI-enabled healthcare services and Story Health, a Cupertino, CA-based digital company involved in specialty care delivery. Image courtesy: Guidehealth christine.book Mon, 07/15/2024 - 12:20 July 15, 2024 — Guidehealth , an artificial intelligence (AI)-enabled healthcare services company, has announced a strategic deal with Stor
HCPLive
JULY 15, 2024
An analysis of data from the NV-HOPE study calls attention to lower rates of HBV and HCV screening among low-income US veterans versus the general US veteran population.
Med Page Today
JULY 15, 2024
(MedPage Today) -- Pemafibrate was tied to potential prevention of leg and foot ulcers in type 2 diabetes, a silver lining to the PROMINENT trial's otherwise disappointing cardiovascular results. In an exploratory analysis, pemafibrate was tied.
Journal of Clinical Investigation - Cardiology
JULY 15, 2024
Pathogenic variants in valosin-containing protein (VCP) cause multisystem proteinopathy (MSP), a disease characterized by multiple clinical phenotypes including inclusion body myopathy, Paget’s disease of the bone, and frontotemporal dementia (FTD). How such diverse phenotypes are driven by pathogenic VCP variants is not known. We found that these diseases exhibit a common pathologic feature: ubiquitinated intranuclear inclusions affecting myocytes, osteoclasts, and neurons.
HCPLive
JULY 15, 2024
A case series analysis indicated that switching from aflibercept to faricimab could be a safe and effective option for patients with treatment-resistant nAMD.
Journal of Clinical Investigation - Cardiology
JULY 15, 2024
The melanocortin-3 receptor (MC3R) regulates GABA release from agouti-related protein (AgRP) nerve terminals and thus tonically suppresses multiple circuits involved in feeding behavior and energy homeostasis. Here, we examined the role of the MC3R and the melanocortin system in regulating the response to various anorexigenic agents. The genetic deletion or pharmacological inhibition of the MC3R, or subthreshold doses of an MC4R agonist, improved the dose responsiveness to glucagon-like peptide
Medical Xpress - Cardiology
JULY 15, 2024
Dialysis patients using a more traditional home hemodialysis procedure have lower incidence of cardiovascular disease than patients using a less invasive peritoneal catheter for dialysis at home, according to a study led by a University of Cincinnati College of Medicine researcher.
Science Daily - Heart Disease
JULY 15, 2024
Monitoring of heart rate and physical activity using consumer wearable devices was found to have clinical value for comparing the response to two treatments for atrial fibrillation and heart failure.
HCPLive
JULY 15, 2024
In this episode, John Buse, MD, PhD, discusses the background, expected prevalence, reaction to results, and the importance of the second part of the CATALYST trial.
Medical Xpress - Cardiology
JULY 15, 2024
A study published in Nature Medicine examined if a commercially-available fitness tracker and smartphone could continuously monitor the response to medications, and provide clinical information similar to in-person hospital assessment.
Journal of Clinical Investigation - Cardiology
JULY 15, 2024
Cutaneous leishmaniasis caused by Leishmania parasites exhibits a wide range of clinical manifestations. Although parasites influence disease severity, cytolytic CD8+ T cell responses mediate disease. Although these responses originate in the lymph node, we found that expression of the cytolytic effector molecule granzyme B was restricted to lesional CD8+ T cells in Leishmania-infected mice, suggesting that local cues within inflamed skin induced cytolytic function.
Becker's Hospital Review - Cardiology
JULY 15, 2024
"Discover the new Jay & Lori Bergman Heart Hospital at Ascension Saint Joseph-Joliet, honoring the couple's philanthropic legacy and supporting advanced cardiac
Medical Xpress - Cardiology
JULY 15, 2024
Overall rates of long-term survival following stroke are improving, but Black individuals experience worse long-term outcomes compared to white individuals, according to University of Cincinnati research published online July 15 in Neurology.
HCPLive
JULY 15, 2024
Individuals with both psoriasis and hypertension have approximately a 2-fold increased mortality risk, which is greater than the mortality risk for psoriasis or hypertension alone.
Cardiovascular Diabetology
JULY 15, 2024
BMI variability has been associated with increased cardiovascular disease risk in individuals with type 2 diabetes, however comparison between clinical studies and real-world observational evidence has been la.
Medical Xpress - Cardiology
JULY 15, 2024
A new study suggests that reducing systolic blood pressure below the clinically safe threshold of 120 mmHg over time may produce slight health-protective benefits against late-life dementia and help reduce racial and ethnic disparities in both hypertension and hypertension control.
HCPLive
JULY 15, 2024
A new study shows RA is linked to an increased risk of hematological tumors and bladder, lung, and liver cancer compared to the general population.
American College of Cardiology
JULY 15, 2024
In this episode, Drs. Erin Michos and Christie Ballantyne examine the importance of testing and identifying lipoprotein(a) (Lp[a]) levels in patients, research highlighting trends in populations at risk, and the genetic factors involved in assessment.
Journal of Clinical Investigation - Cardiology
JULY 15, 2024
Mutations in the tumor-suppressor genes BRCA1 and BRCA2 resulting in BRCA1/2 deficiency are frequently identified in breast, ovarian, prostate, pancreatic, and other cancers. Poly(ADP-ribose) polymerase (PARP) inhibitors (PARPis) selectively kill BRCA1/2-deficient cancer cells by inducing synthetic lethality, providing an effective biomarker-guided strategy for targeted cancer therapy.
HCPLive
JULY 15, 2024
These findings highlight clinician versus patient perceptions of chronic pruritus assessment using patient-reported outcome measures.
Cardiovascular Diabetology
JULY 15, 2024
The atherogenic index of plasma (AIP) is a critical metric for predicting cardiovascular outcomes. However, its associations with cardiovascular disease mortality (CVM) and all-cause mortality (ACM) remain unc.
HCPLive
JULY 15, 2024
An academic dermatologist describes how JAK inhibitors compare with other systemic treatments for atopic dermatitis and provides clinical insights on when to use which treatments.
Journal of Cardiothoracic Surgery
JULY 15, 2024
Cardiac arrest after coronary artery bypass grafting (CABG) is a serious complication with low survival rate. The prognosis of patients with cardiac arrest in the general ward is worse than that in the intensi.
Physiologically Speaking
JULY 15, 2024
Greetings! Do you have burning questions about the best workout routines, tips for optimizing nutrition, or how to maintain your cardiovascular health? Or perhaps you're curious about my daily health practices and what my training routine looks like? Now's your chance to get those answers! I’m excited to announce that I'll be hosting a special Q&A session exclusively for you.
Journal of Cardiothoracic Surgery
JULY 15, 2024
The feasibility of percutaneous intramyocardial septal radiofrequency ablation (PIMSRA) for the treatment of hypertrophic obstructive cardiomyopathy (HOCM) has been previously reported. However, limited invest.
HCPLive
JULY 15, 2024
Christopher Bunick, MD, PhD, advises on when to consider systemic treatments and the frequency of moving to advanced treatments for patients with moderate to severe atopic dermatitis.
MIBHS
JULY 15, 2024
If you’ve recently experienced a heart attack, heart surgery, or been diagnosed with heart disease, your doctor has likely recommended cardiac rehabilitation. This medically supervised program is designed to help you recover and improve your cardiovascular health through exercise, education, and lifestyle modifications. While cardiac rehab may seem like an added burden during an already challenging time, it plays a crucial role in your recovery and long-term well-being.
HCPLive
JULY 15, 2024
An atopic dermatitis expert discusses the primary and secondary efficacy endpoints and treatment goals commonly assessed in clinical trials for moderate to severe atopic dermatitis.
Medical Xpress - Cardiology
JULY 15, 2024
About one-third of adults have high blood pressure. Two-thirds of these have uncontrolled high blood pressure.
HCPLive
JULY 15, 2024
Ruth Ann Vleugels, MD, MPH, MBA, provides an overview of oral JAK inhibitors approved for the treatment of atopic dermatitis and describes what makes them an attractive therapeutic option.
Expert insights. Personalized for you.
145 
Let's personalize your content